New update gardening needed for this important case:
"I have now heard from the Court of Appeal that I have been granted permission to proceed with my appeal. This is very significant news. In the appeal I have argued that cross sex hormones should not be provided in a private clinic or where there is a disagreement between parents, unless there has been authorisation by the Court. This applies even if the child is 16 years old because of the lifelong risks of this controversial treatment, concerns about the clinical guidelines provided by WPATH and the requirement in the NHS for an independent second opinion from a multi-disciplinary team. One of the reasons the judge stated in the Order granting permission to appeal was:
‘There is a compelling reason for an appeal to be heard, in particular as to whether a court could, or ever should, override the decision of a young person who is over 16 and has capacity to consent to treatment which is being offered by a treating doctor in the UK in circumstances where the treatment which is being offered privately, whilst not lifesaving or sustaining, is irreversible, highly controversial and could not be provided in accordance with some of the recommendations contained in the Cass Review.’
This is the first case in which the higher courts will consider the Cass Review. It will be highly significant for parents, children, doctors and future cases. My hope is that the outcome will be greater protection for vulnerable children from an unsafe controversial treatment that has irreversible lifelong consequences (sterilisation being one of many). This is especially concerning when there is a two tier approach to treating children with gender dysphoria – a cautious approach in the NHS which requires a second independent opinion after lengthy psycho-social intervention, and an approach in the private sector that does not have these protections. "